BiotechTube
Home/Biomendics/Karen M. McGuire, PhD
KM

Karen M. McGuire, PhD

CEO, Founder

Biomendics

Therapeutic Areas

Rare Dermatologic Disorders

Biomendics Pipeline

DrugIndicationPhase
MTORX™ (Lead Program)Epidermolysis Bullosa Simplex (EBS)Phase 2
MTORX™ PlatformEpidermolytic Ichthyosis (EI)Preclinical

Leadership Team at Biomendics

MK
Mike Kessel, MBA
Board Member
View full Biomendics profile